Skip to main content

Live Vivos Therapeutics, Inc. Common Stock Share Price Chart

O H L

Vivos Therapeutics, Inc. Common Stock Performance Overview

Days Range
▼
$0.15Low
$0.15High

Markets Today

Previous Close$0.15
Open$0.15
Volume622,544
Day's Range$0.15 - $0.15
52W Range$0.13 - $3.42
Market Cap$3.00 M

Historical Performance

1M Returns-13.06
3M Returns-66.50
6M Returns-88.50
1Y Returns-95.24
5Y Returns-99.84
10Y ReturnsNA

Vivos Therapeutics, Inc. Common Stock Fundamentals

Market Cap$3.00 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$17.44 M
ROE TTM-6.55
EPS TTM$-1.88
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-18.59 M
Profit Margin-121.37
Market Cap$3.00 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$17.44 M
ROE TTM-6.55
EPS TTM$-1.88
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-18.59 M
Profit Margin-121.37

Vivos Therapeutics, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$3.02 M$3.82 M$6.78 M$3.82 M$5.14 M$5.15 M
Gross Profit +$1.51 M$2.11 M$3.94 M$2.99 M$3.06 M$2.95 M
Operating Income -$3.92 M-$4.87 M-$4.73 M-$6.38 M-$6.62 M-$4.83 M
EBITDA -$3.74 M-$4.56 M-$4.35 M-$5.94 M-$6.16 M-$4.31 M
Interest Expense $0$0$0$0$0$0
Depreciation $177.00 K$306.00 K$384.00 K$442.00 K$454.00 K$511.00 K
Income Before Tax -$3.86 M-$5.01 M-$5.40 M-$6.95 M-$7.75 M-$5.52 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$3.86 M-$5.01 M-$5.40 M-$6.95 M-$7.75 M-$5.52 M
Net Profit Margin -128.12%-131.23%-79.61%-181.85%-150.77%-107.18%

Vivos Therapeutics, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $0$0$1.00 K$1.00 K$1.00 K$1.00 K
Reserve & Surplus -$108.05 M-$113.06 M-$118.46 M-$125.36 M-$133.04 M-$138.52 M
Non-Current Liabilities $2.17 M$15.02 M$15.68 M$8.63 M$8.37 M$7.74 M
Current Liabilities $4.70 M$6.43 M$7.44 M$18.08 M$17.94 M$20.39 M
Total Liabilities $6.88 M$21.45 M$23.11 M$26.70 M$26.31 M$28.13 M
Fixed Assets $3.67 M$7.35 M$7.81 M$7.80 M$7.37 M$7.28 M
Current Assets $3.61 M$6.73 M$5.79 M$4.38 M$4.82 M$4.21 M
Total Assets $11.28 M$26.03 M$25.64 M$25.15 M$25.04 M$24.14 M

Vivos Therapeutics, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$3.86 M-$5.01 M-$5.40 M-$6.95 M-$7.75 M-$5.52 M
Operating Cash Flow -$3.80 M-$3.49 M-$4.16 M-$3.81 M-$6.01 M-$3.15 M
Investing Cash Flow -$122.00 K-$5.91 M$83.00 K-$1.58 M-$18.00 K-$416.00 K
Financing Cash Flow $0$11.46 M$2.76 M$4.33 M$6.11 M$3.23 M
Change in Cash -$3.92 M$2.06 M-$1.31 M-$1.06 M$81.00 K-$336.00 K

Vivos Therapeutics, Inc. Common Stock Return Calculator

The Vivos Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$15
Invested Amount$10,000
Est. Returns$-9,985
Invest in USA Stock Today

About Vivos Therapeutics, Inc. Common Stock

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

FAQs

Vivos Therapeutics, Inc. Common Stock (VVOS) share price as of October 3, 2026 is $0.14. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Vivos Therapeutics, Inc. Common Stock (VVOS) Share by opening an international trading account with Angel One.
Purchasing Vivos Therapeutics, Inc. Common Stock (VVOS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Vivos Therapeutics, Inc. Common Stock (VVOS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Vivos Therapeutics, Inc. Common Stock (VVOS) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Vivos Therapeutics, Inc. Common Stock on October 3, 2026, is $3.00 M.
Vivos Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Vivos Therapeutics, Inc. Common Stock (VVOS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL